Sinovac Biotech Ltd (NASDAQ:SVA)

8.12
Delayed Data
As of Feb 22
 +0.025 / +0.31%
Today’s Change
4.60
Today|||52-Week Range
8.67
+3.05%
Year-to-Date
No recent news for Sinovac Biotech Ltd.

Today’s Trading

Previous close8.10
Today’s open8.10
Day’s range8.10 - 8.16
Volume29,995
Average volume (3 months)175,534
Market cap$461.5M
Data as of 3:59pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)-168.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+7.44%
P/E ratio24.5
Price/Sales4.64
Price/Book3.99

Competitors

 Today’s
change
Today’s
% change
CRBPCorbus Pharmaceutica...-0.25-3.21%
DEPODepomed Inc-0.05-0.67%
GLYCGlycoMimetics Inc-1.03-4.22%
AVEOAveo Pharmaceuticals...-0.08-2.72%
Data as of 4:00pm ET, 02/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$72.4M
Annual profit (last year)-$3.1M
Net profit margin-4.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Wei Dong Yin
Chief Financial Officer &
Vice President
Nan Wang
Corporate headquarters
Beijing, Beijing

Forecasts